Profit

Prefer Wockhardt Among Pharma Stocks: Anand Rathi

PUBLISHED ON: December 1, 2015 | Duration: 9 min, 53 sec

facebooktwitteremailkoo
loading..
Chandan Taparia, derivative analyst at Anand Rathi, is positive on Wockhardt. He says the stock has held above Rs 1,650 level recently and is expected to test Rs 1,750-1,770 levels going ahead.
ALSO WATCH
"Tesla Factory In India Will Be Game-Changer": Ex-Chief Economic Advisor To NDTV

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com